Feb 2 (Reuters) - Novo Nordisk said on Monday its experimental next-generation weight-loss drug CagriSema showed greater ...

Wegovy pills are now available in the U.S., offering a prescription-based, convenient alternative for weight management ...

This could finally be the start of the drugmaker's comeback.

Wegovy pill achieved the fastest drug launch in U.S. history with rapid prescription growth since its January rollout.

Skye Bioscience has published 52-week data on its investigational obesity drug combination, linking the cocktail to 22.3% ...

With just a few months to go before Eli Lilly expects to launch its own oral GLP-1 obesity drug, Novo Nordisk is making the ...

Jan 30 (Reuters) - Novo Nordisk's Wegovy pill hit over 26,000 U.S. prescriptions in the second full week after its launch, ...

Skye Bioscience reports Phase 2a data showing nimacimab plus semaglutide led to over 22% weight loss at 52 weeks, with lower ...

Anything that helps Americans lose weight, reduces treatment barriers and makes care more affordable should be welcomed. But ...

Americans seeking to lose weight now have a new option – taking Wegovy as a daily pill, rather than a weekly injection.

A NEW jab set to rival the likes of Mounjaro and Wegovy helped people lose up to 22 per cent of their body weight in less ...

By Sriparna Roy Jan 23 (Reuters) - Novo Nordisk's Wegovy pill was prescribed more than 18,000 times in the U.S. in the first ...